Ad-blocker Detected - Your browser has an ad-blocker enabled, please disable it to ensure your attendance is not impacted, such as CPD tracking (if relevant). For technical help, contact Support.
Day 2 - 6. Atropine for Myopia Control in the Australian Context – What Concentration & For How Long? (TX) (MCQS)
Samantha Lee presents on Atropine for Myopia Control in the Australian Context – What Concentration & For How Long? Duration:30 minutes
Synopsis: The debate over what is the optimal atropine concentration continues. Studies in East Asia, Australia, and other parts of the world have suggested that there is no one-concentration-fits-all approach. With the known rebound effects after stopping treatment, when is a safe time to cease therapy?
Learning Objectives
Identify factors to consider when deciding the concentration of atropine to use
How to decide on when to cease 0.01% atropine therapy for myopia control
The GDPR does not specifically apply to Optometry Australia / Optometry WA as the latter does not have an establishment in the EU nor intentionally engage in targeted marketing to EU individuals specifically. In relation to the management of member data Optometry Australia's current Privacy Act is fully compliant with the respective GDPR data regulations.
We use cookies to ensure you get the best experience on our platform and by continuing to use this site you agree that we can save them on your device. For more information, please read our privacy policy.
